Conferences

SUO 2023: Evolution of the Urologic Oncologist December 1, 2023

SUO 2023: Decipher Genomic Classifier on Initial Prostate Biopsy is Associated with Gleason Score Upgrading on Final Radical Prostatectomy Pathology December 1, 2023

SUO 2023: Optimizing Care for Women: Gynecologic Considerations for the Urologic Oncologist December 1, 2023

SUO 2023: Long-term Outcomes of Bladder-Sparing Therapy Compared to Upfront Radical Cystectomy in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer in an International Cohort December 1, 2023

SUO 2023: Factors Associated with PSMA Positivity at Low PSA After Radical Prostatectomy December 1, 2023

SUO 2023: Decipher Genomic Classifier Score on Initial Biopsy is Associated with Progression from Active Surveillance to Treatment in Prostate Cancer December 1, 2023

SUO 2023: Systemic Therapy: Choosing Among Neoadjuvant/adjuvant Approaches for Upper Tract Urothelial Carcinoma December 1, 2023

SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy December 1, 2023

SUO 2023: Grade and Volume Progression and Its Association with the Decipher Genomic Classifier Using Patients Enrolled in a Prospective Active Surveillance Protocol December 1, 2023

SUO 2023: SWOG 2210: Neoadjuvant Carboplatin for High-Risk Localized Prostate Cancer with Germline BRCA1/2 Mutations December 1, 2023

SUO 2023: From Incision to Intervals: Fine-Tuning Uro-Oncological Follow-Up November 30, 2023

SUO 2023: Defining the Biology of Upper Tract Urothelial Carcinoma and How This Shapes Therapy November 30, 2023

SUO 2023: Trials in Upper Tract Urothelial Carcinoma and Unmet Needs November 30, 2023

SUO 2023: FALCON: Gaining Consensus on Focal Therapy for Localized Prostate Cancer November 30, 2023

SUO 2023: NePtune - A Phase 2 Study of Neoadjuvant PARP Inhibition followed by Radical Prostatectomy in Patients with Unfavorable Intermediate-Risk or High-Risk Prostate Cancer with BRCA1/2 Gene Alterations November 30, 2023

SUO 2023: Drug Costs and Pricing Highlights from the Health Policy Poster Session November 30, 2023

SUO 2023: Late Breaking Abstract - Primary Chemoablation for Recurrent Low Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer: The ENVISION Trial November 30, 2023

SUO 2023: Late Breaking Abstract: First Results from BOND-003, a Phase 3 Study of Intravesical Cretostimogene Grenadenorepvec Monotherapy for Patients with High-Risk BCG Unresponsive NMIBC November 30, 2023

SUO 2023: The Role of Biomarkers for UTUC Risk Stratification November 30, 2023

SUO 2023: UTUC: Chemoablation and Renal Preservation is the Future November 30, 2023

Page 1 of 536